HPC › Bio › Glossary
Insulin resistance is a metabolic state in which skeletal muscle, liver, and adipose tissue fail to respond normally to circulating insulin, reducing glucose uptake and compelling the pancreas to secrete increasing amounts of insulin. Once the pancreas can no longer compensate, blood glucose climbs and type 2 diabetes becomes clinically manifest.
The condition exists on a spectrum; clinically relevant resistance is often present years before blood glucose crosses diagnostic thresholds.
How it works
At the cellular level, insulin binds surface receptors on muscle, liver, and fat cells, triggering a cascade through insulin receptor substrate-1 (IRS-1) and phosphoinositide 3-kinase (PI3K) that causes GLUT4 glucose transporters to migrate to the cell membrane. In resistant tissue this signalling pathway is blunted, GLUT4 translocation falls sharply, and insulin-stimulated glucose uptake is severely reduced. Skeletal muscle accounts for roughly 80% of whole-body insulin-stimulated glucose disposal under normal conditions, so impaired muscle sensitivity alone is sufficient to destabilise glycaemic control.1
The primary cellular mechanism is ectopic lipid accumulation in liver and skeletal muscle. Excess diacylglycerol within plasma membrane fractions activates novel protein kinase C (nPKC) isoforms, which phosphorylate IRS-1 and block the insulin signalling cascade at an early step.1 The liver is not a passive bystander: hepatic insulin resistance drives excess glucose output during fasting, which raises blood sugar even before skeletal muscle resistance becomes clinically apparent. Dysregulated adipose tissue compounds the problem by releasing excess free fatty acids that worsen ectopic lipid loading throughout the body.3
Compensatory hyperinsulinaemia initially keeps blood glucose near normal, but its relationship with cellular sensitivity is contested. The traditional view treats hyperinsulinaemia as a downstream consequence of peripheral resistance; newer evidence raises the possibility that chronically elevated insulin can itself drive receptor downregulation, reinforcing the resistant state.43 The causal direction has not been settled.
Example
A sedentary office worker with a decade of moderate overweight begins noticing poor energy after lunch and increasing difficulty maintaining concentration through afternoon tasks. Fasting glucose tests return normal results for years, yet continuous glucose monitoring would reveal exaggerated postprandial spikes followed by sharp troughs. Hepatic insulin resistance is already producing excess overnight glucose output, and skeletal muscle uptake after each meal is substantially reduced.
Standard fasting glucose tests can read normal for years while insulin resistance is already well established in liver and muscle.
Why it matters
Insulin resistance is the defining pathophysiological feature of type 2 diabetes and metabolic syndrome; it also independently predicts cardiovascular disease through mechanisms that include dyslipidaemia, hypertension, and chronic low-grade inflammation.3 The cellular lesion precedes clinical diagnosis by a decade or more, which means the window for reversing it through lifestyle intervention opens far earlier than standard screening suggests.
The performance consequences extend beyond metabolic disease. Brain insulin resistance impairs hippocampal-dependent memory, working memory, and executive function; peripheral hyperinsulinaemia reduces central insulin signalling, and the resulting deficit promotes tau phosphorylation and amyloid-beta toxicity, placing cerebral insulin resistance on a plausible causal pathway to Alzheimer's disease.2 For an otherwise healthy adult in middle age, reduced cognitive flexibility and attentional control are measurable before blood glucose is clinically abnormal. Insulin sensitivity, in this frame, is a direct performance variable rather than a distant disease risk.
What causes insulin resistance?+
Ectopic lipid accumulation in skeletal muscle and liver is the primary cellular cause; excess diacylglycerol activates enzymes that block the insulin signalling cascade at IRS-1. The upstream drivers are caloric surplus, visceral adiposity, sedentary behaviour, and poor sleep. Genetic susceptibility determines how quickly lipid accumulates at a given level of energy imbalance.{{cite:10.1152/physrev.00063.2017}}{{cite:10.1038/s41574-025-01114-y}}
Can insulin resistance be reversed through diet and exercise?+
Yes, substantially. A single aerobic exercise session improves insulin sensitivity for 24-72 hours via GLUT4 upregulation; resistance training adds durable capacity by expanding skeletal muscle mass. A 5-10% reduction in body weight, combined with reduced intake of high-glycaemic-index carbohydrates, significantly lowers HOMA-IR by reducing ectopic lipid in liver and muscle.{{cite:10.1152/physrev.00063.2017}}{{cite:10.1038/s41574-025-01114-y}}
How does insulin resistance affect the brain and cognition?+
Brain insulin resistance impairs hippocampal memory, working memory, and executive function in otherwise healthy adults. Peripheral hyperinsulinaemia reduces the central insulin signal, and the deficit promotes tau phosphorylation and amyloid-beta pathology linked to Alzheimer's disease, making cerebral insulin sensitivity a direct determinant of cognitive performance, not merely a future disease risk.{{cite:10.1152/physrev.00032.2015}}
Is insulin resistance the same as type 2 diabetes?+
No. Insulin resistance is a cellular lesion that can persist for a decade or more before type 2 diabetes develops. Diabetes is diagnosed when the pancreas can no longer produce sufficient insulin to maintain normal blood glucose. Insulin resistance is necessary but not sufficient for type 2 diabetes; pancreatic beta-cell failure is what closes the gap.{{cite:10.1007/s00125-021-05505-4}}{{cite:10.1038/s41574-025-01114-y}}
